Close
FINDING CURES TOGETHER<sup>SM</sup>
  • Home
  • Award-Lectureship Detail

AACR Princess Takamatsu Memorial Lectureship

Nomination Status Closed
Nomination Deadline 08/16/2017
Generously Supported By The Princess Takamatsu Cancer Research Fund (Japan).


Description

Nomination Instructions

The AACR Princess Takamatsu Memorial Lectureship was established and first presented in 2007 in honor of the late Princess Takamatsu of Japan. During her extraordinary life, Her Imperial Highness Princess Takamatsu expended tremendous efforts toward the public and humanitarian cause of the eradication of cancer. She is regarded as an honored and respected figure in Japan, the United States, and within the international cancer research community as a whole.

Learn more about Princess Takamatsu.

This lectureship will recognize an individual scientist whose novel and significant work has had or may have a far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer, and who embodies the dedication of the Princess to multinational collaborations. The recipient of the Twelfth Annual Lectureship will present a major award lecture during the AACR Annual Meeting 2018 in Chicago, IL, USA (April 14-18, 2018).

The lecturer will receive an unrestricted honorarium of US $10,000, support for the winner and a guest to attend the AACR Annual Meeting, and a commemorative item serving as tangible witness to the singular honor of his/her selection.

Eligibility Criteria

  • Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry or government.

  • The lectureship will be presented to an individual investigator.

  • Institutions or organizations are not eligible for the lectureship.

Contact Information

awards@aacr.org

Nomination Procedure

Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science. Candidates may not nominate themselves.

Nomination materials to be submitted are:

1) Nomination letter which must:

  • be addressed to the Selection Committee; be written in English; and not exceed 1,000 words;

  • specify the AACR award for which the candidate is being nominated;

  • contain a concise description of the candidate's novel and significant work in cancer research and dedication to multinational collaborations;

  • contain publications supporting these contributions directly referenced within the letter (if applicable); and

  • be signed with a handwritten signature by the nominator(s).

2) Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications. Word and PDF files will be accepted.

3) Summary Statement. A statement, no more than 50 words, summarizing the candidate's research accomplishments for which he or she is being nominated.

Nominations must be emailed to awards@aacr.org by 4 p.m. U.S. ET on Wednesday, August 16, 2017. Paper nominations cannot be accepted. Full nomination instructions and program guidelines are available through the link below.

Program Guidelines and Nomination Instructions

Download the Adobe Acrobat Reader here.

Selection Process

​Candidates will be considered by a Selection Committee of international cancer leaders appointed by the president of the AACR. Selection of the lecturer will be made on the basis of the novel and significant work, its far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer, and his or her embodiment of the dedication of the Princess to multinational collaborations. No regard will be given to age, race, gender, nationality, geographic location or religious or political views. After careful deliberations by the committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision.